Intravascular treatment catheters

US11272982B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11272982-B2
Application numberUS-201916511947-A
CountryUS
Kind codeB2
Filing dateJul 15, 2019
Priority dateDec 9, 2004
Publication dateMar 15, 2022
Grant dateMar 15, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides devices and methods for decalcifying an aortic valve. The methods and devices of the present invention break up or obliterate calcific deposits in and around the aortic valve through application or removal of heat energy from the calcific deposits.

First claim

Opening claim text (preview).

What is claimed is: 1. A method comprising: advancing a catheter within vasculature of a patient to a treatment site within a body lumen of the patient; deploying an expandable distal basket from the catheter, wherein the expandable distal basket comprises a plurality of elongate members, and wherein removing the expandable distal basket from the catheter allows the expandable distal basket to transform from a low-profile delivery configuration to an expanded deployed configuration in which one or more elongate members of the plurality of elongate members contact a wall of the body lumen, wherein the plurality of elongate members comprise a plurality of electrodes arranged along the plurality of elongate members, wherein the plurality of electrodes are configured to be positioned in contact with the wall of the body lumen when the distal basket is in the expanded deployed configuration, and wherein at least two of the electrodes are at different longitudinal positions along the distal basket; delivering energy to generate an electric field to target tissue adjacent the body lumen using the plurality of electrodes; and delivering a pharmaceutical agent into the body lumen through a plurality of infusion ports or outlets, wherein the plurality of infusion ports or outlets are distributed along at least one elongate member of the plurality of elongate members and are interspersed among and distinct from the plurality of electrodes. 2. The method of claim 1 , wherein the plurality of elongate members are fabricated from shape-memory material. 3. The method of claim 1 , wherein the plurality of elongate members comprise a metal. 4. The method of claim 1 , wherein the plurality of elongate members comprise a plastic. 5. The method of claim 1 , wherein the expandable distal basket is configured to self-expand upon being removed from the catheter. 6. The method of claim 1 , further comprising mechanically actuating the expandable distal basket from the low-profile delivery configuration to the expanded deployed configuration after removing the expandable distal basket from the catheter. 7. The method of claim 1 , wherein the plurality of electrodes are arranged in a staggered configuration along the plurality of elongate members, and wherein delivering the electric field comprises selectively energizing a subset of the plurality of electrodes to produce a selected treatment electric field. 8. The method of claim 1 , wherein delivering energy to generate the electric field comprises delivering a non-pulsed thermal RF electric field. 9. The method of claim 1 , wherein delivering energy to generate the electric field comprises delivering a pulsed electric field. 10. The method of claim 1 , wherein a plurality of electrodes are carried by each elongate member. 11. The method of claim 1 , wherein the plurality of infusion ports or outlets are configured to allow infusion of the pharmaceutical agent before, during, and/or after delivering the electric field.

Assignees

Inventors

Classifications

  • Decalcification of valves · CPC title

  • in body cavities or body tracts, e.g. by using catheters · CPC title

  • using a circulating cryogenic fluid · CPC title

  • in direct contact with, or very close to, the obstruction or concrement (for removing obstructions in blood vessels by laser A61B18/245) · CPC title

  • with suction of debris · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11272982B2 cover?
The present invention provides devices and methods for decalcifying an aortic valve. The methods and devices of the present invention break up or obliterate calcific deposits in and around the aortic valve through application or removal of heat energy from the calcific deposits.
Who is the assignee on this patent?
Twelve Inc
What technology area does this patent fall under?
Primary CPC classification A61B18/1492. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).